Khare, A. 2023. Case Report Management of Refractory Gout with Tumor Necrosis Factor Inhibitor and Febuxostat: Management of Refractory Gout with Tumor Necrosis Factor Inhibitor and Febuxostat. Journal of Bones & Muscles Health. 1, 2 (Jan. 2023), 79–81.